Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Reiterated by

Needham & Company LLC reaffirmed their hold rating on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) in a report released on Wednesday morning, Benzinga reports. A number of other equities research analysts also recently weighed in on AMPH. JPMorgan Chase & Co. began coverage on shares of Amphastar Pharmaceuticals in a research note on […]

Related Keywords

China , United States , France , Michaela Zasloff , , Boone Capital Management , Jpmorgan Chase Co , Amphastar Pharmaceuticals Stock Down , Td Asset Management Inc , Amphastar Pharmaceuticals Inc , Amphastar Pharmaceuticals Company Profile , Needham Company , Epoch Investment Partners Inc , Victory Capital Management Inc , News Ratings For Amphastar Pharmaceuticals Daily , Jacobs Levy Equity Management Inc , Securities Exchange Commission , Amphastar Pharmaceuticals , Free Report , Moderate Buy , Pharmaceuticals Stock Down , Get Free Report , Director Michael , Exchange Commission , Management Inc , Investment Partners , Capital Management , Jacobs Levy Equity Management , Levy Equity Management , Primatene Mist , Amphastar Pharmaceuticals Daily ,